Survival of Indemnities Representations Warranties Etc Clause Example from Business Contracts

This example Survival of Indemnities Representations Warranties Etc clause appears in 9 contracts from 3 companies

Survival of Indemnities Representations Warranties Etc. The respective indemnities, covenants, agreements, representations, warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by them respectively, pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter, the Company or any person controlling any of them and shall survive delivery of and payment for the Shares. Notwithstanding any termination of this Agreem...ent, including without limitation any termination pursuant to Section 8, the indemnity and contribution and reimbursement agreements contained in Sections 7 and 9 and the covenants, representations, warranties set forth in this Agreement shall not terminate and shall remain in full force and effect at all times. View More
Found in Sarepta Therapeutics, Inc. contract
Sarepta Therapeutics, Inc. Contracts

Underwriting Agreement, March 5, 2019 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named... (Filed With SEC on March 7, 2019)

Underwriting Agreement, October 13, 2021 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse... (Filed With SEC on October 15, 2021)

Underwriting Agreement, dated November 8, 2018, among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC, as... (Filed With SEC on November 9, 2018)

5,020,921 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on September 23, 2016)

2,102,000 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on June 10, 2016)

3,250,000 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on October 6, 2015)

7,650,000 Shares SareptaTherapeutics, Inc. Common Stock ($0.0001 par value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on July 26, 2017)

NOVAVAX INC Contracts

27,693,000 Shares of Common Stock par value $0.01 4,153,950 Over-Allotment Shares Novavax, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 24, 2013)

SANGAMO THERAPEUTICS, INC Contracts

6,100,000 Shares of Common Stock par value $0.001 915,000 Over-Allotment Shares Sangamo BioSciences, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2013)